Background Current practice guidelines for schizophrenia care recommend that
antipsychotic medication is essential for patients' long-term maintenance treatment but their …

Nonadherence with medication treatment is common but difficult to detect in patients with
schizoaffective disorder and schizophrenia, almost half of whom take less than 70% of …

Advances in psychopharmacology have produced medications with substantial efficacy in
the treatment of positive and negative symptoms of schizophrenia and the prevention of …

Despite the advances in the treatment of patients with schizophrenia that have occurred
since the introduction of the second-generation (atypical) antipsychotic agents, a leading …

Nonadherence with medication occurs in all chronic medical disorders. It is a particular
challenge in schizophrenia due to the illness's association with social isolation, stigma, and …

Many patients with schizophrenia are poorly adherent with antipsychotic medications. The
newer, atypical antipsychotics may be more acceptable to patients and result in increased …

Abstract The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) obtained a
sample of 1493 chronic schizophrenia patients. The European First Episode Schizophrenia …

Objective: Antipsychotic medication non-adherence has detrimental effects on patients'
clinical outcome. It is unclear which risk factors affect adherence most and which …

Objectives: This study aimed to prospectively identify the best single predictor and the best
set of predictors of risk for nonadherence with antipsychotic medication in the treatment of …

Non-adherence is a major problem in the treatment of schizophrenia. Its high prevalence,
potentially severe consequences and associated costs make the study of this phenomenon …